|
|
News Breaks | | | | September 19, 2012 | | 10:33 EDT |  | ACHN, STJ, MON, MRO, GMLP, FDP, GLW, CQB, AZN, WBS | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Achillion (ACHN) upgraded to Buy from Neutral at BofA/Merrill... AstraZeneca (AZN) upgraded to Neutral from Underperform at Exane BNP Paribas... Chiquita Brands (CQB) upgraded to Buy from Hold at BB&T... Corning (GLW) upgraded to Buy from Neutral at Goldman... Fresh Del Monte (FDP) upgraded to Buy from Hold at BB&T... Golar LNG Partners (GMLP) upgraded to Outperform from Market Perform at Wells Fargo... Marathon Oil (MRO) upgraded to Outperform from Neutral at Credit Suisse... Monsanto (MON) upgraded to Conviction Buy from Buy at Goldman... St. Jude Medical (STJ) upgraded to Outperform from Market Perform at Wells Fargo... Webster Financial (WBS) upgraded to Strong Buy from Outperform at Raymond James. | |
|
News For ACHN;AZN;CQB;GLW;FDP;GMLP;MRO;MON;STJ;WBS From The Last 14 Days Check below for free stories on ACHN;AZN;CQB;GLW;FDP;GMLP;MRO;MON;STJ;WBS the last two weeks. |
|
|
| May 20, 2013 | | 11:12 EDT |  | STJ | St. Jude Medical to evaluate defibrilator lead related to reported death
 Subscribe for More Information | | | 08:04 EDT |  | MON | BofA/Merrill's U.S. chemicals analyst holds an analyst/industry conference call
Subscribe for More Information | | | 07:41 EDT | | MRO | Mitsubishi UFJ Securities to host an energy tour
May Energy Tour travels throughout the Houston and San Antonio area on May 20-23. | | | May 17, 2013 | | 10:36 EDT | | AZN | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
Subscribe for More Information | | | 09:30 EDT | | GLW | PPG says court issues opinion on Pittsburgh Corning reorganization
Subscribe for More Information | | | 08:41 EDT | | AZN | Impax commenced shipment of authorized generic Zomig
Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013. | | | May 16, 2013 | | 10:30 EDT | | ACHN | Achillion management to meet with Maxim
Subscribe for More Information | | | 08:05 EDT | | STJ | St. Jude Medical's 3-D vessel reconstruction system approved in Europe
St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. | | | May 15, 2013 | | 17:18 EDT | | MRO | BP Capital gives quarterly update on stakes
Subscribe for More Information | | | 06:06 EDT | | ACHN | Achillion appoints Dr. David Apelian as Chief Medical Officer
Achillion (ACHN) appointed David Apelian, M.D., Ph.D., MBA, to the position of Executive VP and Chief Medical Officer, effective May 28. Dr. Apelian wll assume responsibility for the clinical development of Achillion's portfolio of compounds to treat HCV. In addition, Achillion also expanded its clinical operations group with the recent addition of Kevin Kucharski, formerly head of clinical operations at Pharmasset (VRUS), who will serve as Senior VP of Clinical Operations. | | | | May 14, 2013 | | 17:48 EDT | | MON | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | 08:09 EDT | | STJ | St. Jude Medical announces first patient enrolled in EnligHTN III study
Subscribe for More Information | | | 07:24 EDT | | AZN | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. | | | 07:20 EDT | | GLW | JPMorgan to host a conference
Subscribe for More Information | | | May 13, 2013 | | 16:53 EDT |  | AZN | Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says
Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link | | | 16:25 EDT |  | MON | On The Fly: Closing Wrap
Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. | | | 15:55 EDT | | AZN | Optimer gets first round bids from AstraZeneca, Cubist, Bloomberg says
Subscribe for More Information | | | 12:20 EDT | | MON | On The Fly: Midday Wrap
Subscribe for More Information | | | 10:28 EDT | | MON | Supreme Court upholds Monsanto win over seed patents
Subscribe for More Information | | | 10:09 EDT | | GLW | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | |
|
|
|
|
|
|
